Mikio Danbara

459 total citations
23 papers, 363 citations indexed

About

Mikio Danbara is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Mikio Danbara has authored 23 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Mikio Danbara's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and T-cell and Retrovirus Studies (3 papers). Mikio Danbara is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and T-cell and Retrovirus Studies (3 papers). Mikio Danbara collaborates with scholars based in Japan, United States and France. Mikio Danbara's co-authors include Masaaki Higashihara, S Shionoya, Fuyuki Ishikawa, Hiroyuki Sato, Jun‐ichi Nakayama, Tohru Akahoshi, Yoshinaga Takayama, Yuhsaku Kanoh, S. Ohtani and Kôji Miyazaki and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Mikio Danbara

21 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikio Danbara Japan 10 173 99 88 76 50 23 363
Abd Aziz Ibrahim Japan 8 172 1.0× 35 0.4× 87 1.0× 162 2.1× 61 1.2× 12 397
Anna Margrét Halldórsdóttir Iceland 11 84 0.5× 23 0.2× 64 0.7× 52 0.7× 79 1.6× 22 343
Barbara Burroni France 9 77 0.4× 77 0.8× 93 1.1× 49 0.6× 224 4.5× 37 447
Xiangyang Huang China 12 117 0.7× 27 0.3× 78 0.9× 24 0.3× 41 0.8× 30 386
Carlos Cerveró Spain 7 63 0.4× 76 0.8× 284 3.2× 92 1.2× 17 0.3× 16 388
Yoshitaka Kinoshita Japan 8 130 0.8× 27 0.3× 130 1.5× 16 0.2× 78 1.6× 33 425
Herlander Marques Portugal 9 112 0.6× 36 0.4× 35 0.4× 19 0.3× 59 1.2× 25 247
Loren Herrera Hernandez United States 8 358 2.1× 31 0.3× 44 0.5× 42 0.6× 37 0.7× 17 481
Yuxing Shan China 9 93 0.5× 30 0.3× 246 2.8× 53 0.7× 86 1.7× 11 478
Keiichi Iwanami Japan 12 85 0.5× 31 0.3× 248 2.8× 41 0.5× 100 2.0× 25 423

Countries citing papers authored by Mikio Danbara

Since Specialization
Citations

This map shows the geographic impact of Mikio Danbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Danbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Danbara more than expected).

Fields of papers citing papers by Mikio Danbara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikio Danbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Danbara. The network helps show where Mikio Danbara may publish in the future.

Co-authorship network of co-authors of Mikio Danbara

This figure shows the co-authorship network connecting the top 25 collaborators of Mikio Danbara. A scholar is included among the top collaborators of Mikio Danbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikio Danbara. Mikio Danbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Kôji, Shinji Kunishima, Ryuji Ishii, et al.. (2015). Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Hematology. 20(10). 587–592. 30 indexed citations
2.
Danbara, Mikio, et al.. (2013). Lenalidomide-induced acute lung injury in case of multiple myeloma. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 513–516. 1 indexed citations
3.
Yoshida, Tsutomu, Guoqin Wang, Shunsuke Miyamoto, et al.. (2013). Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells. Acta Haematologica. 130(4). 230–237. 15 indexed citations
4.
Nakano, Hiroko, et al.. (2012). The differentiating and apoptotic effects of 2-aza-5′-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochemical and Biophysical Research Communications. 420(4). 775–781. 13 indexed citations
5.
Miyazaki, Kôji, et al.. (2012). Surface CD3 expression proceeds through both myosin regulatory light chain 9 (MYL9)-dependent and MYL9-independent pathways in Jurkat cells. Journal of Smooth Muscle Research. 48(5_6). 137–147. 6 indexed citations
6.
Danbara, Mikio, et al.. (2011). 1. Prognosis and Prognostic Factors in Lymphoid Malignancy.. Nihon Naika Gakkai Zasshi. 100(7). 1898–1908.
7.
Watanabe, Masaaki, Akitaka Shibuya, Mikio Danbara, et al.. (2010). Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection. Liver International. 31(3). 340–347. 12 indexed citations
8.
Nakamura, Takeshi, Masaharu Tokoro, Tomiteru Togano, et al.. (2010). A case of giardiasis expressing severe systemic symptoms and marked hypereosinophilia. Parasitology International. 59(3). 487–489. 4 indexed citations
9.
Yoshida, Tsutomu, Ryouichi Horie, Tomoko Tsuruta, et al.. (2010). Constitutive Activity of Nuclear Transcription Factor κB is Observed in Follicular Lymphoma. Journal of Clinical and Experimental Hematopathology. 50(1). 45–50. 6 indexed citations
10.
Danbara, Mikio, Masafumi Yoshida, Yoshinori Kanoh, et al.. (2009). Flow Cytometric Detection of Small Cell Lung Cancer Cells with Aberrant CD45 Expression in Micrometastatic Bone Marrow. Japanese Journal of Clinical Oncology. 39(11). 771–775. 5 indexed citations
11.
Niitsu, Nozomi, Ryuji Ishii, Kôji Miyazaki, et al.. (2009). Lymphoproliferative Disorders after Immunosuppressive Therapy for Aplastic Anemia: A Case Report and Literature Review. Acta Haematologica. 121(1). 21–26. 6 indexed citations
12.
Miyazaki, Kôji, et al.. (2009). CD20-Positive T-Cell Large Granular Lymphocyte Leukemia: Case Report and Review of the Literature. Internal Medicine. 48(16). 1443–1447. 5 indexed citations
13.
14.
15.
Kanoh, Yuhsaku, Mikio Danbara, Yoshinaga Takayama, et al.. (2004). Analysis of the Oligosaccharide Chain of Human Serum Immunoglobulin G in Patients with Localized or Metastatic Cancer. Oncology. 66(5). 365–370. 31 indexed citations
16.
Danbara, Mikio, et al.. (2002). DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. Molecular Immunology. 38(15). 1161–1166. 24 indexed citations
17.
Danbara, Mikio, et al.. (1998). Development of Pyothorax-Associated Pleural Lymphoma in Relation to Focal Cytokinemic Condition and Epstein-Barr Virus Infection. Acta Haematologica. 99(1). 41–44. 8 indexed citations
18.
Nakayama, Jun‐ichi, et al.. (1996). A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.. PubMed. 13(10). 2265–74. 108 indexed citations
19.
Sato, Hiroshi, et al.. (1995). Biological Characteristics of Chronic Eosinophilic Leukemia Cells with a t(2;5)(p23;q35) Translocation. Leukemia & lymphoma. 19(5-6). 499–505. 9 indexed citations
20.
Sato, Hiroshi, Mikio Danbara, Masato Tamura, & Makoto Morita. (1994). Eosinophilic leukaemia with a t(2;5) (p23;q35) translocation. British Journal of Haematology. 87(2). 404–406. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abd Aziz Ibrahim Breakdown of academic impact, for papers by Anna Margrét Halldórsdóttir Breakdown of academic impact, for papers by Barbara Burroni Breakdown of academic impact, for papers by Xiangyang Huang Breakdown of academic impact, for papers by Carlos Cerveró Breakdown of academic impact, for papers by Yoshitaka Kinoshita Breakdown of academic impact, for papers by Herlander Marques Breakdown of academic impact, for papers by Loren Herrera Hernandez Breakdown of academic impact, for papers by Yuxing Shan Breakdown of academic impact, for papers by Keiichi Iwanami
Rankless by CCL
2026